These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 9380527)

  • 1. [Genetic risk after high dose radioiodine therapy with regard to gonadal dose].
    Ehrenheim C; Hauswirth C; Fitschen J; Martin E; Oetting G; Hundeshagen H
    Nuklearmedizin; 1997 Aug; 36(5):157-66. PubMed ID: 9380527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring.
    Bal C; Kumar A; Tripathi M; Chandrashekar N; Phom H; Murali NR; Chandra P; Pant GS
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):449-55. PubMed ID: 16095849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic administration of 131I for differentiated thyroid cancer: radiation dose to ovaries and outcome of pregnancies.
    Garsi JP; Schlumberger M; Rubino C; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henri-Amar M; Bardet S; de Vathaire F
    J Nucl Med; 2008 May; 49(5):845-52. PubMed ID: 18413399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma.
    Fard-Esfahani A; Hadifar M; Fallahi B; Beiki D; Eftekhari M; Saghari M; Takavar A
    Hell J Nucl Med; 2009; 12(1):37-40. PubMed ID: 19330181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Offsprings of preconceptionally irradiated parents. Final report of a longitudinal study 1976-1994 and recommendations for patients' advisory].
    Herrmann T; Thiede G; Trott KR; Voigtmann L
    Strahlenther Onkol; 2004 Jan; 180(1):21-30. PubMed ID: 14704841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioiodine therapy during an unknown remained pregnancy and radiation exposure of the fetus. A case report.
    Arndt D; Mehnert WH; Franke WG; Woller P; Laude G; Rockel A; Waller M
    Strahlenther Onkol; 1994 Jul; 170(7):408-14. PubMed ID: 8052940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment.
    Chow SM; Yau S; Lee SH; Leung WM; Law SC
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian function after radioiodine therapy in patients with thyroid cancer.
    Souza Rosário PW; Alvarenga Fagundes T; Villas-Boas Fagundes AS; Barroso AL; Lamego Rezende L; Lanza Padrão E; Guimarães VC; Horta AC; Franco M; Purisch S
    Exp Clin Endocrinol Diabetes; 2005 Jun; 113(6):331-3. PubMed ID: 15977100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma.
    Balenović A; Vlasić M; Sonicki Z; Bodor D; Kusić Z
    Coll Antropol; 2006 Dec; 30(4):743-8. PubMed ID: 17243543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment for microcarcinoma of the thyroid--clinical experience.
    Küçük NO; Tari P; Tokmak E; Aras G
    Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.
    Sarkar SD; Beierwaltes WH; Gill SP; Cowley BJ
    J Nucl Med; 1976 Jun; 17(6):460-4. PubMed ID: 944243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malformations in the offspring of women with thyroid cancer treated with radioiodine for the ablation of thyroid remnants.
    do Rosário PW; Barroso AL; Rezende LL; Padrão EL; Borges MA; Purisch S
    Arq Bras Endocrinol Metabol; 2006 Oct; 50(5):930-3. PubMed ID: 17160219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NTP Toxicology and Carcinogenesis Studies of Oxymetholone (CAS NO. 434-07-1) in F344/N Rats and Toxicology Studies of Oxymetholone in B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Aug; 485():1-233. PubMed ID: 12571678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Nitrofurantoin (CAS No. 67-20-9) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1989 Sep; 341():1-218. PubMed ID: 12724784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study.
    Zettinig G; Hanselmayer G; Fueger BJ; Hofmann A; Pirich C; Nepp J; Dudczak R
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1428-32. PubMed ID: 12397459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 3,3'-Dimethylbenzidine Dihydrochloride (CAS No. 612-82-8) in F344/N Rats (Drinking Water Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1991 Jun; 390():1-238. PubMed ID: 12637969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H; Lassmann M; Luster M; Thomas SR; Pacini F; Ceccarelli C; Ladenson PW; Wahl RL; Schlumberger M; Ricard M; Driedger A; Kloos RT; Sherman SI; Haugen BR; Carriere V; Corone C; Reiners C
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.